Praxis Precision Medicines annual capital expenditures (capex)
2019
2020
2021
2022
2023
2024
2025
Praxis Precision Medicines Capital Expenditures (CapEx) Growth & History (PRAX)
Praxis Precision Medicines's capital expenditures (capex) was $56,000 for fiscal 2025.
View full Praxis Precision Medicines company overviewPraxis Precision Medicines annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $56,000 | $56,000 | — |
| 2024 | 2024-12-31 | $0 | −$50,000 | — |
| 2023 | 2023-12-31 | $50,000 | −$394,000 | −88.74% |
| 2022 | 2022-12-31 | $444,000 | −$606,000 | −57.71% |
| 2021 | 2021-12-31 | $1.1M | $1.1M | — |
| 2020 | 2020-12-31 | $0 | −$103,000 | — |
| 2019 | 2019-12-31 | $103,000 | — | — |
Praxis Precision Medicines quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $245,000 | $189,000 | +337.50% |
| Q1 2026 | 2026-03-31 | $62,000 | $62,000 | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $56,000 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $50,000 | $50,000 | — |
| Q3 2023 | 2023-09-30 | $0 | −$45,000 | — |
| Q2 2023 | 2023-06-30 | $0 | −$110,000 | — |
| Q1 2023 | 2023-03-31 | $0 | −$289,000 | — |
| Q4 2022 | 2022-12-31 | $0 | −$531,000 | — |
| Q3 2022 | 2022-09-30 | $45,000 | −$405,000 | −90.00% |
| Q2 2022 | 2022-06-30 | $110,000 | $45,000 | +69.23% |
| Q1 2022 | 2022-03-31 | $289,000 | $285,000 | +7125.00% |
| Q4 2021 | 2021-12-31 | $531,000 | $531,000 | — |
| Q3 2021 | 2021-09-30 | $450,000 | $450,000 | — |
| Q2 2021 | 2021-06-30 | $65,000 | $65,000 | — |
| Q1 2021 | 2021-03-31 | $4,000 | $4,000 | — |
| Q4 2020 | 2020-12-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $0 | — | — |
Praxis Precision Medicines capital expenditures (capex) trends
Over the last five fiscal years, Praxis Precision Medicines's capital expenditures (capex) increased from $0 to $56,000, a change of $56,000. The latest reported quarter, Q2 2026, shows $245,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Praxis Precision Medicines source filings ↗